SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615219-16-000226
Filing Date
2016-11-02
Accepted
2016-11-02 16:43:12
Documents
56
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q flks201693010-q.htm 10-Q 725656
2 EXHIBIT 10.1 flks2016930ex-101.htm EX-10.1 49996
3 EXHIBIT 31.1 flks2016930ex-311.htm EX-31.1 10236
4 EXHIBIT 31.2 flks2016930ex-312.htm EX-31.2 10286
5 EXHIBIT 32.1 flks2016930ex-321.htm EX-32.1 9404
  Complete submission text file 0001615219-16-000226.txt   3971437

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT flks-20160930.xml EX-101.INS 778541
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20160930.xsd EX-101.SCH 25994
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flks-20160930_cal.xml EX-101.CAL 51811
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flks-20160930_def.xml EX-101.DEF 108927
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20160930_lab.xml EX-101.LAB 411043
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20160930_pre.xml EX-101.PRE 234478
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36812 | Film No.: 161968584
SIC: 2834 Pharmaceutical Preparations